Back to Agenda
SESSION 2: GETTING IT RIGHT: SYSTEMATIC COLLECTION OF IMPACT RELEVANT DATA THROUGHOUT THE PRODUCT LIFE-CYCLE
Session Chair(s)
Vicki Edwards, RPH
Vice President, Pharmacovigilance Excellence and International QPPV, Abbvie, United Kingdom
June Raine, MD, MSC, FRCP
Chief Executive, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
This session looks at the generation of impact relevant data as a systematic process considering the need for, the nature of and the approach to data collection throughout a product’s life-cycle.
Speaker(s)
Emma Du Four, MBA
Independent Regulatory and R&D Policy Professional, Independent, United Kingdom
Framework for utilising data to support decision making - Industry experience
Alison Cave
Chief Safety Officer, Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
How could novel technologies and access to real world data facilitate impact research?
Kaisa Immonen
Director of Policy , European Patients' Forum, Belgium
Patients' involvement in generating impact relevant data
Have an account?